Prognostic Impact of Cardiac Damage Across the Spectrum of Aortic Stenosis Severity: Results From a Large Real-World Database

BACKGROUND

A staging classification of aortic stenosis (AS) based on extent of cardiac damage (CD) has been validated in multiple patient (pt) cohorts with severe or moderate AS. However, data for untreated pts across degrees of AS severity are lacking.

METHODS

We analyzed pts with AS in a deidentified real-world dataset including 812,577 echocardiograms (497,086 pts) from 12 US hospitalswith appropriate permissions (egnite Database; egnite, Aliso Viejo, CA, US). Pts >18 years old were classified by AS severity (mild, moderate, severe) and CD staging (as previously described). Outcomes were examined using Kaplan-Meier estimates, with censoring at treatment date for AS/last clinical encounter, and compared using the log-rank test.

RESULTS

Of 313,390 pts with available AS severity assessment, 13,612 had both ≥mild AS and evaluable CD staging. Median (IQR) time from staging to censor/death was 326 (54-751) days. Mild, moderate, or severe AS was diagnosed in 4,791 (35%), 3,591 (26%), and 5,230 (38%) pts, and CD staging was Stage 0, 1, 2, 3, or 4 in 521 (4%), 1,456 (11%), 5,856 (43%), 1,732 (13%), and 4,047 (30%) pts, respectively. Two-year mortality across all AS severities was 8%, 11%, 14%, 26%, and 33% for Stages 0, 1, 2, 3, or 4, respectively, p<0.0001. Higher CD stage was associated with greater mortality at each AS severity (Figure).

CONCLUSIONS

This analysis of untreated pts with AS demonstrates that progressive CD has important prognostic and therapeutic implications across all degrees of AS severity.

Généreux P, Sharma RP, Cubeddu RJ, et al. Prognostic impact of cardiac damage across the spectrum of aortic stenosis severity: results from a large real-world database [abstract]. J Am Coll Cardiol. 2023;81(8 suppl):1930. doi:10.1016/S0735-1097(23)02374-4. (Podium, ACC.23/WCC; March 4–6, 2023; New Orleans, LA.)

Follow egnite on social:

Related Articles

Publications

Mitral Regurgitation and Severe Aortic Stenosis: Clinical Characteristics, Prognostic Impact, and Response to TAVR: Insights From egnite Data

BACKGROUND Aortic stenosis (AS) and mitral regurgitation (MR) frequently co-occur, complicating diagnosis and treatment. We examined current US treatment trends and patient outcomes among patients with severe AS and at least moderate MR. METHODS We analyzed data from 2 992 362 patients (aged ≥18 years) undergoing 5 245 904 echocardiograms at 43 US institutions

"The future of aortic stenosis care requires proactive identification, longitudinal monitoring, and intentional pipeline management."
egnite Research

Rethinking the Aortic Stenosis Pipeline

Aortic stenosis care is shifting from a reactive to a proactive model. Emerging clinical evidence supports earlier identification, closer monitoring, and intentional patient management across the disease continuum. As treatment thresholds evolve, health systems need scalable approaches to identify at-risk patients, close treatment gaps, and ensure timely access to specialist care.

New UI Press Release
Press

egnite Unveils Major CardioCare® Platform Improvements with a New UI that Enables Even Faster and Easier Access to Critical CV Data

The upgrade accelerates a health system’s capability to go from reactive to proactive cardiovascular care along guideline-directed treatment pathways ALISO VIEJO, Calif. — egnite, Inc., a healthcare AI company focused on helping clinicians identify and manage patients with untreated heart disease, today announced significant enhancements to its CardioCare platform, which